Evidence map›Paper›PMID 21741667›Full record

ArticleVirology2011

Nucleocytoplasmic shuttling of the HSV-2 serine/threonine kinase Us3.

Renée L Finnen, Susan M Johnston, Casey E Neron, Bruce W Banfield

Open access · greenAbstract read
In one paragraph

Article in Virology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact, top 87% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Renée L FinnenDepartment of Biomedical and Molecular Sciences, Queen's University, Kingston, Ontario, Canada K7L 3N6.
Susan M Johnston
Casey E Neron
Bruce W Banfield
Queen's University · CA

Funding

Modulation of cell signaling pathways by alphaherpesvirus tegument componentsR01AI048626 · NIAID · UNIVERSITY OF COLORADO DENVER · PI BANFIELD, BRUCE W · 2001 to 2011
$2.5M
CIHR 93804NIAID NIH HHS AI48626NIAID NIH HHS R01 AI048626
6 · The paper itself

Abstract

The alphaherpesvirus serine/threonine kinase Us3 plays diverse roles in virus multiplication and modifies both nuclear and cytoplasmic substrates. We recently reported that treatment of HSV-2 Us3-transfected and HSV-2-infected cells with leptomycin B, an inhibitor of nuclear export mediated by interaction of chromosomal regional maintenance protein (CRM1) with leucine rich nuclear export signals (NESs), resulted in nuclear trapping of Us3. Here, we utilized fluorescence loss in photobleaching to monitor nuclear export of HSV-2 Us3 and confirm that this process proceeds solely via a CRM1-mediated mechanism. Analysis of deletion derivatives of HSV-2 Us3 fused to a nuclear export reporter protein implicated the involvement of NES-like sequences in nuclear export. However, nuclear trapping of HSV-2 Us3 proteins carrying mutations in these potential NESs was not observed, indicating that these sequences are not functional in the context of full-length protein. Our analyses also revealed previously unidentified regions of HSV-2 Us3 that contribute to its kinase activity.

Indexed as

Active Transport, Cell NucleusAnimalsChlorocebus aethiopsGene Expression Regulation, ViralHEK293 CellsHerpesvirus 2, HumanHumansMiceNIH 3T3 CellsProtein Serine-Threonine KinasesVero CellsViral ProteinsProtein Serine-Threonine KinasesUS3 protein, Human herpesvirus 2Viral Proteins

Identifiers

PMID21741667
PMCPMC3152661
OpenAlexW2070326119

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.